ANAVEX LIFE SCIENCES CORP. Derivative Liability, Current
ANAVEX LIFE SCIENCES CORP. (AVXL) had Derivative Liability, Current of $0 as of 2012-09-30, per its 10-K filed 2012-12-31.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2012-12-31
- 2012-09-30: Derivative Liability, Current $0.00.
- 2012-06-30: Derivative Liability, Current $0.00.
- 2012-03-31: Derivative Liability, Current $0.00.
- 2011-12-31: Derivative Liability, Current $12.50K.
| Period end | Derivative Liability, Current |
|---|---|
| 2012-09-30 | $0.00 10-K · filed 2012-12-31 |
| 2012-06-30 | $0.00 10-Q · filed 2012-08-17 |
| 2012-03-31 | $0.00 10-Q · filed 2012-05-15 |
| 2011-12-31 | $12.50K 10-Q · filed 2012-02-14 |
| 2011-09-30 | $67.50K 10-K · filed 2012-12-31 |
| 2011-06-30 | $57.50K 10-Q · filed 2011-08-12 |
| 2010-09-30 | $0.00 10-K · filed 2011-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |